Among a wide range of cancer-derived negative regulators known to contribute to dysfunction or exhaustion of effector T cells, tumor-derived sEV aka TEX are emerging as major negative regulators of anti-tumor immunity and of response to IT. This evidence concerns the gene TEX46 and cancer.